SynBiotic SE, together with its subsidiaries, engages in the pharmaceutical business in Germany and Europe. It is involved in the cultivation, research, development, production, and distribution of medicinal cannabis; industrial hemp; and cannabidiol and cannabinoid-based products. The company was incorporated in 2024 and is based in Düsseldorf, Germany.
Frequently asked questions
What sector does SynBiotic SE (SBX) operate in?
SynBiotic SE belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is SynBiotic SE (SBX) current stock price?
As of the latest data, SynBiotic SE stock price is €0.16, with a previous close of €0.16. SynBiotic SE lost -€0.00 in the last trading session, representing a -1.26% loss.
What is SynBiotic SE (SBX) current market capitalization?
SynBiotic SE market cap is approximately 1.14 million.
What is SynBiotic SE (SBX) Earnings Per Share (EPS)?
The trailing EPS is -€0.31.
Does SynBiotic SE (SBX) pay dividends?
No. SynBiotic SE does not pay a dividend.
What is SynBiotic SE (SBX) beta (volatility) score?
SynBiotic SE has a beta of 0.411, indicating lower volatility than the overall market.